189 related articles for article (PubMed ID: 34384450)
41. IMRT with ¹⁸FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer.
Cihoric N; Tapia C; Krüger K; Aebersold DM; Klaeser B; Lössl K
Radiat Oncol; 2014 Mar; 9():83. PubMed ID: 24661323
[TBL] [Abstract][Full Text] [Related]
42. High dose three-dimensional conformal boost using the real-time tumor tracking radiotherapy system in cervical cancer patients unable to receive intracavitary brachytherapy.
Park HC; Shimizu S; Yonesaka A; Tsuchiya K; Ebina Y; Taguchi H; Katoh N; Kinoshita R; Ishikawa M; Sakuragi N; Shirato H
Yonsei Med J; 2010 Jan; 51(1):93-9. PubMed ID: 20046520
[TBL] [Abstract][Full Text] [Related]
43. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
[TBL] [Abstract][Full Text] [Related]
44. A dose planning study on applicator guided stereotactic IMRT boost in combination with 3D MRI based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Petersen JB; Nielsen SK; Lindegaard JC; Tanderup K
Acta Oncol; 2008; 47(7):1337-43. PubMed ID: 18663651
[TBL] [Abstract][Full Text] [Related]
45. Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer.
Refaat T; Castelain B; Small W; Elsaid A; Lotfy N; Lartigau E; Nickers P
Am J Clin Oncol; 2015 Jun; 38(3):289-93. PubMed ID: 23799285
[TBL] [Abstract][Full Text] [Related]
46. Determining the recommended dose of stereotactic body radiotherapy boost in patients with cervical cancer who are unsuitable for intracavitary brachytherapy: a phase I dose-escalation study.
Ito K; Kito S; Nakajima Y; Shimizuguchi T; Ogawa H; Nihei K; Tanaka H; Kino N; Yasugi T; Karasawa K
Jpn J Clin Oncol; 2019 Sep; 49(9):856-861. PubMed ID: 31112278
[TBL] [Abstract][Full Text] [Related]
47. Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.
Isohashi F; Akino Y; Matsumoto Y; Suzuki O; Seo Y; Tamari K; Sumida I; Sawada K; Ueda Y; Kobayashi E; Tomimatsu T; Nakanishi E; Nishi T; Kimura T; Ogawa K
J Radiat Res; 2021 May; 62(3):494-501. PubMed ID: 33866361
[TBL] [Abstract][Full Text] [Related]
48. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
49. Comparison of Single-fraction and Multi-fraction Stereotactic Radiotherapy for Patients with 18F-fluorodeoxyglucose Positron Emission Tomography-staged Pulmonary Oligometastases.
Siva S; Kirby K; Caine H; Pham D; Kron T; Te Marvelde L; Whalley D; Stevens MJ; Foroudi F; MacManus M; Ball D; Eade T
Clin Oncol (R Coll Radiol); 2015 Jun; 27(6):353-61. PubMed ID: 25698068
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcomes of intensity-modulated radiation therapy (IMRT) and high dose rate brachytherapy as adjuvant therapy after radical hysterectomy for cervical cancer.
Contreras J; Srivastava A; Chundury A; Schwarz JK; Markovina S; Thaker PH; Massad LS; Mutch DG; Powell MA; Grigsby PW; Lin AJ
Int J Gynecol Cancer; 2020 Aug; 30(8):1157-1161. PubMed ID: 32527770
[TBL] [Abstract][Full Text] [Related]
51. Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity.
Marnitz S; Stromberger C; Kawgan-Kagan M; Wlodarczyk W; Jahn U; Schneider A; Ulrich U; Budach V; Köhler C
Strahlenther Onkol; 2010 Oct; 186(10):572-9. PubMed ID: 20936458
[TBL] [Abstract][Full Text] [Related]
52. A comparison between high dose rate brachytherapy and stereotactic body radiotherapy boost after elective pelvic irradiation for high and very high-risk prostate cancer.
Novikov SN; Novikov RV; Merezhko YO; Gotovchikova MY; Ilin ND; Melnik YS; Kanaev SV
Radiat Oncol J; 2022 Sep; 40(3):200-207. PubMed ID: 36200309
[TBL] [Abstract][Full Text] [Related]
53. Image-guided interstitial brachytherapy for recurrent cervical cancer after radiotherapy: A single institution experience.
Ren X; Fu Y; Liu Z; Lin X; Qiu L; Li Y; Li H; Bai Y; Wang T
Front Oncol; 2022; 12():943703. PubMed ID: 35928866
[TBL] [Abstract][Full Text] [Related]
54. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
[TBL] [Abstract][Full Text] [Related]
55. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
56. Adjuvant Small Pelvic Radiotherapy in Patients with Cervical Cancer Having Intermediate Risk Factors Only - Is It Sufficient?
Yuce Sari S; Guler OC; Gultekin M; Onal HC; Yildiz F
Oncol Res Treat; 2017; 40(9):523-527. PubMed ID: 28848218
[TBL] [Abstract][Full Text] [Related]
57. A knowledge-based organ dose prediction tool for brachytherapy treatment planning of patients with cervical cancer.
Yusufaly TI; Kallis K; Simon A; Mayadev J; Yashar CM; Einck JP; Mell LK; Brown D; Scanderbeg D; Hild SJ; Covele B; Moore KL; Meyers SM
Brachytherapy; 2020; 19(5):624-634. PubMed ID: 32513446
[TBL] [Abstract][Full Text] [Related]
58. Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
Chopra S; Dora T; Engineer R; Mechanery S; Agarwal P; Kannan S; Ghadi Y; Swamidas J; Mahantshetty U; Shrivastava SK
Brachytherapy; 2015; 14(6):881-8. PubMed ID: 26409708
[TBL] [Abstract][Full Text] [Related]
59. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
[TBL] [Abstract][Full Text] [Related]
60. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
